BEBT-733

N/A

Report date: 2025/02/24 11:37:36
NME

Base Information

Drug NameBEBT-733
Drug Alias NameBEBT-733
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionProlyl hydroxylase domain-containing protein 2 modulatorsRNA interference
TargetsProlyl hydroxylase domain-containing protein 2
Therapy Area/IndicationsAnemiaRenal Insufficiency, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGuangzhou BeBetter Medicine Technology Co
China Registration ClassN/A

Develop Information

Active CompaniesGuangzhou BeBetter Medicine Technology Co
Inactive CompaniesN/A
Active IndicationsAnemiaRenal Insufficiency, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A